
Lifetime Omics provides AI-powered health diagnostics for researchers and healthcare organizations. It uses its FAIRLYZ data technology to give access to a vast network of health and omics data and to support clinical decisions. The platform enables diagnosis support, treatment planning, risk assessment, and disease prevention through AI-based clinical decision support systems. Categorized as a B2B AI/biotech platform, it targets research institutions, hospitals, and enterprise research programs, with integrations to research workflows. The solution aims to scale globally by enabling cross-institution collaboration and large-scale data-enabled biology insights.

Lifetime Omics provides AI-powered health diagnostics for researchers and healthcare organizations. It uses its FAIRLYZ data technology to give access to a vast network of health and omics data and to support clinical decisions. The platform enables diagnosis support, treatment planning, risk assessment, and disease prevention through AI-based clinical decision support systems. Categorized as a B2B AI/biotech platform, it targets research institutions, hospitals, and enterprise research programs, with integrations to research workflows. The solution aims to scale globally by enabling cross-institution collaboration and large-scale data-enabled biology insights.